Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -34.33%132.25M | -34.33%132.25M | -32.00%148.39M | -30.60%164.18M | -30.22%179.8M | -27.19%201.37M | -27.19%201.37M | -24.86%218.21M | -22.89%236.59M | 6.21%257.67M |
-Cash and cash equivalents | 17.63%41.75M | 17.63%41.75M | 31.55%34.86M | 0.59%28.28M | -8.57%33.03M | -12.27%35.49M | -12.27%35.49M | -58.89%26.5M | -73.33%28.11M | -7.14%36.13M |
-Short-term investments | -45.44%90.5M | -45.44%90.5M | -40.78%113.53M | -34.81%135.91M | -33.75%146.77M | -29.74%165.88M | -29.74%165.88M | -15.15%191.71M | 3.49%208.48M | 8.76%221.54M |
Receivables | -66.46%938K | -66.46%938K | -75.91%1.69M | --2.35M | --3.69M | --2.8M | --2.8M | --7M | ---- | ---- |
-Accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7M | ---- | ---- |
-Accrued interest receivable | -38.99%424K | -38.99%424K | --589K | --374K | --648K | --695K | --695K | ---- | ---- | ---- |
-Other receivables | -75.55%514K | -75.55%514K | --1.1M | --1.97M | --3.04M | --2.1M | --2.1M | ---- | ---- | ---- |
Prepaid assets | 56.28%3.95M | 56.28%3.95M | 39.74%6.12M | -85.34%877K | -82.74%1.17M | -72.38%2.53M | -72.38%2.53M | -43.36%4.38M | 57.21%5.98M | 191.08%6.79M |
Other current assets | 39.84%351K | 39.84%351K | -79.68%190K | -77.49%210K | 22.52%952K | --251K | --251K | 14.30%935K | 36.20%933K | -26.42%777K |
Total current assets | -33.56%137.49M | -33.56%137.49M | -32.16%156.38M | -31.16%167.62M | -30.02%185.61M | -27.57%206.95M | -27.57%206.95M | -22.89%230.52M | -21.79%243.5M | 7.82%265.23M |
Non current assets | ||||||||||
Net PPE | -45.01%4.78M | -45.01%4.78M | -57.58%5.29M | -56.57%5.78M | -42.16%8.02M | -34.03%8.69M | -34.03%8.69M | 124.33%12.48M | 125.95%13.31M | 148.01%13.86M |
-Gross PPE | -20.45%11.22M | -20.45%11.22M | -34.75%11.49M | -36.23%11.72M | -26.84%13.7M | -20.61%14.11M | -20.61%14.11M | 76.57%17.62M | 83.26%18.38M | 97.26%18.72M |
-Accumulated depreciation | -18.91%-6.45M | -18.91%-6.45M | -20.64%-6.2M | -17.18%-5.94M | -16.85%-5.68M | -17.77%-5.42M | -17.77%-5.42M | -16.42%-5.14M | -22.49%-5.07M | -24.58%-4.86M |
Non current accounts receivable | --1.74M | --1.74M | --1.74M | --1.1M | ---- | ---- | ---- | ---- | ---- | ---- |
Non current prepaid assets | -87.66%674K | -87.66%674K | -89.09%674K | -16.11%5.34M | 10.88%5.39M | --5.46M | --5.46M | --6.18M | --6.37M | --4.86M |
Other non current assets | ---- | ---- | ---- | -58.85%79K | -51.33%110K | -80.12%134K | -80.12%134K | -43.97%158K | -31.91%192K | -19.86%226K |
Total non current assets | -49.64%7.19M | -49.64%7.19M | -59.03%7.71M | -38.09%12.3M | -28.66%13.52M | 3.17%14.29M | 3.17%14.29M | 221.92%18.81M | 221.91%19.88M | 222.78%18.95M |
Total assets | -34.60%144.68M | -34.60%144.68M | -34.19%164.09M | -31.69%179.92M | -29.93%199.13M | -26.15%221.24M | -26.15%221.24M | -18.19%249.33M | -17.05%263.38M | 12.83%284.18M |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -55.75%3.65M | -55.75%3.65M | 10.93%3.46M | -9.19%2.26M | 22.32%5.06M | 232.84%8.25M | 232.84%8.25M | 37.20%3.12M | 29.66%2.49M | 204.34%4.14M |
-accounts payable | -55.75%3.65M | -55.75%3.65M | 10.93%3.46M | -9.19%2.26M | 22.32%5.06M | 232.84%8.25M | 232.84%8.25M | 37.20%3.12M | 29.66%2.49M | 204.34%4.14M |
Current accrued expenses | 88.21%5.22M | 88.21%5.22M | -2.65%7.54M | 15.66%7.56M | -7.30%4.96M | 2.97%2.77M | 2.97%2.77M | 129.12%7.75M | 121.67%6.54M | 68.24%5.35M |
Current debt and capital lease obligation | 190.27%8.74M | 190.27%8.74M | 152.30%7.3M | 110.96%5.87M | 66.09%4.44M | 17.43%3.01M | 17.43%3.01M | 117.83%2.9M | 116.50%2.78M | 115.31%2.67M |
-Current debt | --5.22M | --5.22M | --3.91M | --2.61M | --1.3M | ---- | ---- | ---- | ---- | ---- |
-Current capital lease obligation | 17.07%3.53M | 17.07%3.53M | 17.13%3.39M | 17.18%3.26M | 17.29%3.13M | 17.43%3.01M | 17.43%3.01M | 117.83%2.9M | 116.50%2.78M | 115.31%2.67M |
Current liabilities | 14.57%20.33M | 14.57%20.33M | 22.53%20.43M | 27.36%17.5M | 18.45%16.16M | 61.35%17.74M | 61.35%17.74M | 73.76%16.67M | 74.93%13.74M | 95.53%13.64M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -53.29%7.44M | -53.29%7.44M | -42.33%9.61M | -32.39%11.74M | -23.26%13.85M | -14.86%15.92M | -14.86%15.92M | 38.98%16.66M | 41.35%17.37M | 43.53%18.05M |
-Long term debt | -49.24%5.11M | -49.24%5.11M | -36.57%6.35M | -23.74%7.59M | -10.76%8.83M | 2.39%10.07M | 2.39%10.07M | 2.35%10.01M | 2.30%9.95M | 2.25%9.89M |
-Long term capital lease obligation | -60.25%2.33M | -60.25%2.33M | -50.99%3.26M | -43.99%4.15M | -38.44%5.02M | -33.99%5.85M | -33.99%5.85M | 201.31%6.65M | 189.91%7.41M | 181.33%8.15M |
Total non current liabilities | -53.29%7.44M | -53.29%7.44M | -42.33%9.61M | -32.39%11.74M | -23.26%13.85M | -14.86%15.92M | -14.86%15.92M | 38.98%16.66M | 41.35%17.37M | 43.53%18.05M |
Total liabilities | -17.52%27.77M | -17.52%27.77M | -9.89%30.04M | -6.00%29.24M | -5.30%30.01M | 13.37%33.67M | 13.37%33.67M | 54.44%33.33M | 54.44%31.1M | 62.09%31.69M |
Shareholders'equity | ||||||||||
Share capital | 0.00%7K | 0.00%7K | -90.41%7K | 0.00%73K | 2.82%73K | -89.71%7K | -89.71%7K | 7.35%73K | 7.35%73K | 18.33%71K |
-common stock | 0.00%7K | 0.00%7K | -90.41%7K | 0.00%73K | 2.82%73K | -89.71%7K | -89.71%7K | 7.35%73K | 7.35%73K | 18.33%71K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -23.87%-434.5M | -23.87%-434.5M | -30.07%-414.28M | -33.37%-393.97M | -37.38%-372.42M | -40.93%-350.76M | -40.93%-350.76M | -38.05%-318.5M | -38.77%-295.4M | -37.84%-271.09M |
Paid-in capital | 2.44%551.57M | 2.44%551.57M | 2.45%548.22M | 3.13%544.97M | 3.39%541.82M | 3.62%538.46M | 3.62%538.46M | 3.85%535.11M | 3.35%528.43M | 21.95%524.03M |
Gains losses not affecting retained earnings | -24.62%-162K | -24.62%-162K | 115.57%107K | 53.61%-385K | 32.12%-355K | 85.92%-130K | 85.92%-130K | 53.11%-687K | 28.69%-830K | 33.12%-523K |
Total stockholders'equity | -37.67%116.92M | -37.67%116.92M | -37.94%134.05M | -35.13%150.69M | -33.02%169.12M | -30.50%187.57M | -30.50%187.57M | -23.73%215.99M | -21.89%232.28M | 8.68%252.49M |
Total equity | -37.67%116.92M | -37.67%116.92M | -37.94%134.05M | -35.13%150.69M | -33.02%169.12M | -30.50%187.57M | -30.50%187.57M | -23.73%215.99M | -21.89%232.28M | 8.68%252.49M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |